Spots Global Cancer Trial Database for intratumoral
Every month we try and update this database with for intratumoral cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Study of the Safety and Efficacy of MIW815 With PDR001 in Patients With Advanced/Metastatic Solid Tumors or Lymphomas | NCT03172936 | Solid Tumors an... | MIW815 PDR001 | 18 Years - | Novartis | |
| Intratumoral Injection of LTX-315 in Combination With Pembrolizumab in Advanced Melanoma | NCT04796194 | Advanced Melano... | LTX-315 in comb... | 18 Years - | Lytix Biopharma AS | |
| A Phase 1/2 Safety Study of Intratumorally Dosed INT230-6 | NCT03058289 | Breast Cancer Head and Neck C... Squamous Cell C... Lymphoma Pancreatic Canc... Liver Cancer Colon Cancer Lung Cancer Bile Duct Cance... Chordoma of Sac... Sarcoma | INT230-6 anti-PD-1 antib... anti-CTLA-4 ant... | 18 Years - | Intensity Therapeutics, Inc. | |
| Feasibility of Holmium-166 Micro Brachytherapy in Head and Neck Tumors | NCT02975739 | Radioisotopes Head and Neck N... | Holmium-166 (po... | 18 Years - | UMC Utrecht | |
| Phase 1/2a Study of SQ3370 in Patients With Advanced Solid Tumors | NCT04106492 | Cancer | SQ3370 | 18 Years - | Shasqi, Inc. | |
| A Study Investigating the Safety and Tolerability of an Immune Treatment in Cancer Patients With Lesions to the Skin | NCT04059588 | Cancer Solid Tumor Cancer of Skin | 2141 V-11 | 18 Years - | Rockefeller University | |
| Study of IT STX-001 in Patients With Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab | NCT06249048 | Advanced Solid ... | STX-001 Keytruda® | 18 Years - | Strand Therapeutics Inc. | |
| Intratumoral Cancer Chemotherapy Through a Flexible Bronchoscope as an Adjunct to Brachytherapy | NCT00379665 | Carcinoma, Non-... | Cisplatin | 20 Years - 80 Years | Southwestern Regional Medical Center | |
| Feasibility of Holmium-166 Micro Brachytherapy in Head and Neck Tumors | NCT02975739 | Radioisotopes Head and Neck N... | Holmium-166 (po... | 18 Years - | UMC Utrecht | |
| Safety Study of Intratumoral Injection of Clostridium Novyi-NT Spores to Treat Patients With Solid Tumors That Have Not Responded to Standard Therapies | NCT01924689 | Solid Tumor Mal... | Clostridium nov... | 18 Years - | BioMed Valley Discoveries, Inc | |
| Dose Escalation and Cohort Expansion of Safety and Tolerability Study of Intratumoral rAd.CD40L (ISF35) in Combination of Systemic Pembrolizumab in Patients With Refractory Metastatic Melanoma | NCT02719015 | Melanoma | rAd.CD40L Pembrolizumab | 18 Years - | M.D. Anderson Cancer Center | |
| Percutaneous Holmium Injection in Pancreatic Cancer | NCT05880472 | Pancreas Cancer | Intratumoral | 18 Years - | Radboud University Medical Center | |
| Study of BO-112 With Radiotherapy and Nivolumab for Metastatic Refractory NSCLC | NCT05265650 | Non-Small Cell ... | BO-112 in combi... Tissue Biopsies | 18 Years - | Clinica Universidad de Navarra, Universidad de Navarra | |
| Radiation Therapy and Intratumoral Autologous Dendritic Cells in Soft Tissue Sarcomas (STS) | NCT01347034 | Soft Tissue Sar... | External Beam R... Autologous Dend... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Safety Study of Intratumoral Injection of Clostridium Novyi-NT Spores to Treat Patients With Solid Tumors That Have Not Responded to Standard Therapies | NCT01924689 | Solid Tumor Mal... | Clostridium nov... | 18 Years - | BioMed Valley Discoveries, Inc | |
| A Phase 1/2 Safety Study of Intratumorally Dosed INT230-6 | NCT03058289 | Breast Cancer Head and Neck C... Squamous Cell C... Lymphoma Pancreatic Canc... Liver Cancer Colon Cancer Lung Cancer Bile Duct Cance... Chordoma of Sac... Sarcoma | INT230-6 anti-PD-1 antib... anti-CTLA-4 ant... | 18 Years - | Intensity Therapeutics, Inc. | |
| Phase 1/2a Study of SQ3370 in Patients With Advanced Solid Tumors | NCT04106492 | Cancer | SQ3370 | 18 Years - | Shasqi, Inc. | |
| A Clinical Trial Assessing BT-001 Alone and in Combination With Pembrolizumab in Metastatic or Advanced Solid Tumors | NCT04725331 | Metastatic Canc... Soft Tissue Sar... Merkel Cell Car... Melanoma Triple Negative... Non Small Cell ... | BT-001 Pembrolizumab [... | 18 Years - | Transgene | |
| Study of the Safety and Efficacy of MIW815 With PDR001 in Patients With Advanced/Metastatic Solid Tumors or Lymphomas | NCT03172936 | Solid Tumors an... | MIW815 PDR001 | 18 Years - | Novartis | |
| Intratumoral Injection of LTX-315 in Combination With Pembrolizumab in Advanced Melanoma | NCT04796194 | Advanced Melano... | LTX-315 in comb... | 18 Years - | Lytix Biopharma AS | |
| A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in Bladder Cancer | NCT05483868 | Non-muscle-inva... Muscle-Invasive... | AU-011 AU-011 in Combi... AU-011 in Combi... | 18 Years - | Aura Biosciences | |
| INVINCIBLE TRIAL: Intratumoral INT230-6 in Breast Cancer | NCT04781725 | Breast Cancer | INT230-6 Saline injectio... | - | Ottawa Hospital Research Institute | |
| A Study to Evaluate the Safety and Effectiveness of ILIxadencel Administered Into Tumors in Combination With Checkpoint Inhibitor (CPI) in Patients With ADvanced Cancer | NCT03735290 | Carcinoma, Squa... Gastric Adenoca... Gastroesophagea... Non-small Cell ... | ilixadencel Pembrolizumab | 18 Years - | Mendus | |
| Radiation Therapy and Intratumoral Autologous Dendritic Cells in Soft Tissue Sarcomas (STS) | NCT01347034 | Soft Tissue Sar... | External Beam R... Autologous Dend... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
